Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-03

Clinical Trial Update: Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

View source ↗

Summary

The document notes that the University of Utah-sponsored clinical trial on spinal abnormalities in Neurofibromatosis Type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Neurofibromatosis Type 1 | Status: COMPLETED